A Multicenter Randomized Trial Assessing the Efficacy of Helium/Oxygen in Severe Exacerbations of Chronic Obstructive Pulmonary Disease

被引:34
|
作者
Jolliet, Philippe [1 ]
Ouanes-Besbes, Lamia [2 ]
Abroug, Fekri [2 ]
Ben Khelil, Jalila [3 ]
Besbes, Mohamed [3 ]
Garnero, Aude [4 ]
Arnal, Jean-Michel [4 ]
Daviaud, Fabrice [5 ]
Chiche, Jean-Daniel [5 ]
Lortat-Jacob, Benoit [6 ]
Diehl, Jean-Luc [6 ]
Lerolle, Nicolas [7 ]
Mercat, Alain [7 ]
Razazi, Keyvan [8 ]
Brun-Buisson, Christian [8 ]
Durand-Zaleski, Isabelle [9 ]
Texereau, Joelle [5 ,10 ]
Brochard, Laurent [11 ,12 ,13 ,14 ]
机构
[1] Ctr Hosp talier Uiv Vaudois, Intens Care & Burn Unit, Lausanne, Switzerland
[2] Fattouma Bourguiba Univ Hosp, Monastir, Tunisia
[3] Abderrahmen Mami Hosp, Ariana, Tunisia
[4] St Musse Hosp, Toulon, France
[5] Cochin Hosp, Paris, France
[6] Georges Pompidou European Hosp, Paris, France
[7] Angers Univ Hosp, Angers, France
[8] Henri Mondor Hosp, Creteil, France
[9] Univ Paris Est, INSERM, UMR 955, Creteil, France
[10] Air Liquide Sante Int, Med R&D, Jouy En Josas, France
[11] Univ Hosp Geneva, Intens Care Unit, Geneva, Switzerland
[12] St Michaels Hosp, Li Ka Shing Inst, Toronto, ON, Canada
[13] St Michaels Hosp, Keenan Res Ctr, Toronto, ON, Canada
[14] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada
关键词
chronic obstructive pulmonary disease; noninvasive ventilation; helium; outcome; NONINVASIVE PRESSURE SUPPORT; HELIUM-OXYGEN MIXTURES; INSPIRATORY EFFORT; VENTILATION; AIR; EXERCISE; DELIVERY; FAILURE;
D O I
10.1164/rccm.201601-0083OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: During noninvasive ventilation (NIV) for chronic obstructive pulmonary disease (COPD) exacerbations, helium/oxygen (heliox) reduces the work of breathing and hypercapnia more than air/O-2, but its impact on clinical outcomes remains unknown. Objectives: To determine whether continuous administration of heliox for 72 hours, during and in-between NIV sessions, was superior to air/O-2 in reducing NIV failure (25-15%) in severe hypercapnic COPD exacerbations. Methods: This was a prospective, randomized, open-label trial in 16 intensive care units (ICUs) and 6 countries. Inclusion criteria were COPD exacerbations with Pa-CO2 >= 45 mm Hg, pH <= 7.35, and at least one of the following: respiratory rate >= 25/min, Pa-O2 <= 50 mm Hg, and oxygen saturation (arterial [Sa(O2)] or measured by pulse oximetry [Sp(O2)]) <= 90%. A 6-month follow-up was performed. Measurements and Main Results: The primary endpoint was NIV failure (intubation or death without intubation in the ICU). The secondary endpoints were physiological parameters, duration of ventilation, duration of ICU and hospital stay, 6-month recurrence, and rehospitalization rates. The trial was stopped prematurely (445 randomized patients) because of a low global failure rate (NIV failure: air/O-2 14.5% [n = 32]; heliox 14.7% [n = 33]; P=0.97, and time to NIV failure: heliox group 93 hours [n = 33], air/O-2 group 52 hours [n = 32]; P = 0.12). Respiratory rate, pH, Pa-CO2, and encephalopathy score improved significantly faster with heliox. ICU stay was comparable between the groups. In patients intubated after NIV failed, patients on heliox had a shorter ventilation duration (7.4 +/- 7.6 d vs. 13.6 +/- 12.6 d; P = 0.02) and a shorter ICU stay (15.8 +/- 10.9 d vs. 26.7 +/- 21.0 d; P = 0.01). No difference was observed in ICU and 6-month mortality. Conclusions: Heliox improves respiratory acidosis, encephalopathy, and the respiratory rate more quickly than air/O-2 but does not prevent NIV failure. Overall, the rate of NIV failure was low.
引用
收藏
页码:871 / 880
页数:10
相关论文
共 50 条
  • [1] A multicenter, randomized trial of noninvasive ventilation with helium-oxygen mixture in exacerbations of chronic obstructive lung disease
    Maggiore, Salvatore Maurizio
    Richard, Jean-Christophe M.
    Abroug, Fekri
    Diehl, Jean Luc
    Antonelli, Massimo
    Sauder, Philippe
    Mancebo, Jordi
    Ferrer, Miquel
    Lellouche, Francois
    Lecourt, Laurent
    Beduneau, Gaetan
    Brochard, Laurent
    CRITICAL CARE MEDICINE, 2010, 38 (01) : 145 - 151
  • [2] The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease - A randomized crossover trial
    Laude, EA
    Duffy, NC
    Baveystock, C
    Dougill, B
    Campbell, MJ
    Lawson, R
    Jones, PW
    Calverley, PM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (08) : 865 - 870
  • [3] Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease
    Pilcher, Janine
    Weatherall, Mark
    Perrin, Kyle
    Beasley, Richard
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (03) : 287 - 293
  • [4] Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial
    Vita, Patrizio
    Stanziola, Anna
    Confalonieri, Marco
    Libertucci, Daniela
    Oggionni, Tiberio
    Rottoli, Paola
    Paciocco, Giuseppe
    Tuzzolino, Fabio
    Martino, Lavinia
    Beretta, Marta
    Callari, Adriana
    Amaducci, Andrea
    Badagliacca, Roberto
    Poscia, Roberto
    Meloni, Federica
    Refini, Rosa Metella
    Geri, Pietro
    Baldi, Sergio
    Ghio, Stefano
    D'Alto, Michele
    Argiento, Paola
    Sofia, Matteo
    Guardamagna, Mara
    Pezzuto, Beatrice
    Vizza, Carmine Dario
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (02) : 166 - 174
  • [5] Early versus Late Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients with Acute Exacerbations: A Randomized Trial
    Puhan, Milo A.
    Spaar, Anne
    Frey, Martin
    Turk, Alexander
    Braendli, Otto
    Ritscher, Daniel
    Achermann, Eva
    Kaelin, Rainer
    Karrer, Werner
    RESPIRATION, 2012, 83 (06) : 499 - 506
  • [6] Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
    Sanjay Sethi
    Paul W Jones
    Marlize Schmitt Theron
    Marc Miravitlles
    Ethan Rubinstein
    Jadwiga A Wedzicha
    Robert Wilson
    Respiratory Research, 11
  • [7] Oxygen therapy during exacerbations of chronic obstructive pulmonary disease
    Agustí, AGN
    Carrera, M
    Barbé, F
    Muñoz, A
    Togores, B
    EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (04) : 934 - 939
  • [8] Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease
    Brill, Simon E.
    Wedzicha, Jadwiga A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 1241 - 1252
  • [9] Noninvasive ventilation with helium-oxygen rather than air-oxygen in acute exacerbations of chronic obstructive disease?
    Hilbert, G
    CRITICAL CARE MEDICINE, 2003, 31 (03) : 990 - 991
  • [10] Treatment of exacerbations of chronic obstructive pulmonary disease
    Avdeev, S. N.
    Truschenko, N., V
    Gaynitdinova, V. V.
    Soe, A. K.
    Nuralieva, G. S.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (12) : 68 - 75